118 related articles for article (PubMed ID: 2593464)
1. [Muramyl dipeptide derivative and its clinical application].
Tsubura E
Kekkaku; 1989 Nov; 64(11):731-9. PubMed ID: 2593464
[TBL] [Abstract][Full Text] [Related]
2. [Restorative effect of muroctasin; MDP-Lys (L18) [DJ-7041] on leukopenia in urogenital cancer patients treated with chemotherapy].
Oishi K; Takeuchi H; Yoshida O; Nakagawa K; Fukuyama T; Okamoto K; Kihara Y; Okuno H; Shirahase T; Tomoyoshi T
Hinyokika Kiyo; 1989 Mar; 35(3):527-36. PubMed ID: 2660519
[TBL] [Abstract][Full Text] [Related]
3. Restorative activity of muroctasin on leukopenia associated with anticancer treatment.
Tsubura E; Nomura T; Niitani H; Osamura S; Okawa T; Tanaka M; Ota K; Nishikawa H; Masaoka T; Fukuoka M
Arzneimittelforschung; 1988 Jul; 38(7A):1070-4. PubMed ID: 3190800
[TBL] [Abstract][Full Text] [Related]
4. Restorative effect of muroctasin on leukopenia caused by anticancer chemotherapy in lung cancer. Comparative study by envelope method.
Fukuoka M; Takada M; Takifuji N; Sakai N; Ryu S; Masuda N; Matsui K; Negoro S; Kusunoki Y; Tubura E
Arzneimittelforschung; 1989 Jan; 39(1):90-3. PubMed ID: 2719748
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effect of muroctasin on experimental leukopenia induced by cyclophosphamide or irradiation in mice.
Nakajima R; Ishida Y; Yamaguchi F; Otani T; Ono Y; Nomura M; Une T; Osada Y
Arzneimittelforschung; 1988 Jul; 38(7A):986-92. PubMed ID: 3263871
[TBL] [Abstract][Full Text] [Related]
6. [Restorative effect of muroctasin, MDP-Lys (L 18), on leukopenia caused by anticancer chemotherapy in lung cancer--comparative study by envelope method].
Takada M; Fukuoka M; Takifuji N; Sakai N; Ryu S; Masuda N; Matsui K; Negoro S; Kusunoki Y; Tsubura E
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3095-101. PubMed ID: 3142367
[TBL] [Abstract][Full Text] [Related]
7. Activation of the cytokine network by muroctasin as a remedy for leukopenia and thrombopenia.
Furuse K; Sakuma A
Arzneimittelforschung; 1989 Aug; 39(8):915-7. PubMed ID: 2684174
[TBL] [Abstract][Full Text] [Related]
8. Hematological response to the new synthetic muramyl dipeptide derivative muroctasin after chemotherapy in patients with malignant lymphoma. A randomized crossover trial.
Hiraoka A; Masaoka T; Satoh T; Ota K; Oyama A; Horiuchi A; Hasegawa H; Nagai K; Kosaki M; Kanemaru A
Arzneimittelforschung; 1988 Oct; 38(10):1499-501. PubMed ID: 3058133
[TBL] [Abstract][Full Text] [Related]
9. [Muroctasin, a muramyl dipeptide derivative].
Sosnowska D; Dzierzbicka K; Myśliwski A; Kołodziejczyk AM
Postepy Hig Med Dosw; 1992; 46(5):521-30. PubMed ID: 1298958
[TBL] [Abstract][Full Text] [Related]
10. Activation of immune responses by muroctasin.
Akasaki M
Arzneimittelforschung; 1988 Jul; 38(7A):976-7. PubMed ID: 3056427
[TBL] [Abstract][Full Text] [Related]
11. Synergistic generation of tumoricidal macrophages by muroctasin and interferon-gamma.
Nagao S; Sato K; Osada Y
Arzneimittelforschung; 1988 Jul; 38(7A):999-1002. PubMed ID: 3142490
[TBL] [Abstract][Full Text] [Related]
12. Muroctasin. A new muramyl dipeptide derivative, MDP-Lys(L18).
Arzneimittelforschung; 1988 Jul; 38(7A):951-1074. PubMed ID: 3190801
[No Abstract] [Full Text] [Related]
13. Mutagenicity studies of muroctasin.
Shimada H; Hattori C; Sato T
Arzneimittelforschung; 1988 Jul; 38(7A):1031-3. PubMed ID: 3056424
[TBL] [Abstract][Full Text] [Related]
14. Specific binding sites of muroctasin on murine macrophages.
Akasaki M; Masayasu H; Tsukada W; Takegoshi T
Arzneimittelforschung; 1988 Jul; 38(7A):978-80. PubMed ID: 3190804
[TBL] [Abstract][Full Text] [Related]
15. Local tolerance of muroctasin injection in rabbits.
Nakashima K; Jindo T; Nomura M
Arzneimittelforschung; 1988 Jul; 38(7A):1038-9. PubMed ID: 3190798
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of non-specific resistance to infection by muroctasin.
Otani T; Une T; Osada Y
Arzneimittelforschung; 1988 Jul; 38(7A):969-76. PubMed ID: 3056426
[TBL] [Abstract][Full Text] [Related]
17. Production of colony-stimulating factor from macrophages by muroctasin.
Yamaguchi F; Akahane K; Takashi T; Tsukada W
Arzneimittelforschung; 1988 Jul; 38(7A):983-6. PubMed ID: 3263870
[TBL] [Abstract][Full Text] [Related]
18. [Augmentation of immune defense mechanisms of the lung by romurtide].
Hasegawa J; Satoh A; Yagi K; Chida K
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jun; 33(6):605-11. PubMed ID: 7666614
[TBL] [Abstract][Full Text] [Related]
19. Phase I study and clinical pharmacological study of muroctasin.
Ichihara N; Kanazawa R; Sasaki S; Ono K; Otani T; Yamaguchi F; Une T
Arzneimittelforschung; 1988 Jul; 38(7A):1043-69. PubMed ID: 3263868
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of macrophages by muroctasin to produce colony-stimulating factors.
Akahane K; Yamaguchi F; Kita Y; Une T; Osada Y
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):179-83. PubMed ID: 1692219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
